ClinicalTrials.gg
CompletedNCT07931846Updated Nov 12, 2026

Comparison of Quadratus Lumborum and Paravertebral Blocks for Postoperative Analgesia in Inguinal Hernia Surgery

An interventional study of General Aneasthesia in Patients Underwent Elective Open Inguinal Hernia Surgery Under Spinal Anesthesia and Postoperative Analgesia in Inguinal Hernia Surgery, sponsored by Gaziosmanpasa Research and Education Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Gaziosmanpasa Research and Education Hospital · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Mar 2023, registered Nov 2026).
Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
124
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 77 studies in Hernia, Inguinal with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Hernia, Inguinal · Turkey.

Enrollment
8th of 60
124 · median 80
Started
2023
with 7 others
No phase
52 of 77
11 open now
Registered
77th of 77
by date
Lead sponsor
3 of 77
Gaziosmanpasa Research and Education Hospital

Among the 77 studies in Hernia, Inguinal with a site in Turkey, this one is the 8th largest by enrollment of the 60 interventional ones that give a count, is one of 8 that started in 2023, is one of 52 with no phase, and was the 77th registered.

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

12 of the 77 studies in Hernia, Inguinal with a site in Turkey are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Hernia, Inguinal with a site in Turkey, or all of them as a file.
02

Study summary

This prospective, randomized, single-blind clinical trial evaluated the postoperative analgesic efficacy of anterior quadratus lumborum block, posterior quadratus lumborum block, and paravertebral block in patients undergoing elective open inguinal hernia surgery under spinal anesthesia.

A total of 124 patients were included and allocated to four groups: control, anterior quadratus lumborum block, posterior quadratus lumborum block, and paravertebral block.

The primary outcome was total analgesic consumption during the first 24 postoperative hours. Secondary outcomes included the requirement for rescue analgesia, time to first rescue analgesic administration, postoperative pain scores at rest and during movement, and postoperative nausea and vomiting.

Read the detailed description

Patients undergoing elective open inguinal hernia repair under spinal anesthesia were included in this prospective randomized clinical trial.

Standard monitoring included electrocardiography, non-invasive blood pressure measurement, and peripheral oxygen saturation. Spinal anesthesia was performed at the L3-L4 or L4-L5 intervertebral space using a 25-gauge spinal needle, with 12-14 mg intrathecal bupivacaine.

At the end of surgery, patients received intravenous dexketoprofen 50 mg. Participants were subsequently allocated to one of four study groups.

Patients in the anterior quadratus lumborum block group received an ultrasound-guided unilateral anterior/transmuscular quadratus lumborum block with 20 mL of 0.25% bupivacaine.

Patients in the posterior quadratus lumborum block group received an ultrasound-guided unilateral posterior quadratus lumborum block with 20 mL of 0.25% bupivacaine.

Patients in the paravertebral block group received an ultrasound-guided unilateral thoracic paravertebral block with 20 mL of 0.25% bupivacaine.

Patients in the control group did not receive an additional regional block. Postoperatively, patients received intravenous paracetamol 1 g four times daily. Rescue analgesia was administered when the postoperative pain score was ≥4 according to the study analgesia protocol.

Postoperative assessments were performed at 1, 4, 8, 12, and 24 hours.

03

Conditions studied

  • Patients Underwent Elective Open Inguinal Hernia Surgery Under Spinal Anesthesia
  • Postoperative Analgesia in Inguinal Hernia Surgery

Browse trials for

Keywords

  • Quadratus Lumborum Block
  • Paravertebral Block
  • Postoperative Analgesia
  • Inguinal Hernia Surgery
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age between 18 and 65 years

      • Scheduled for elective open inguinal hernia surgery
      • Surgery performed under spinal anesthesia
      • (ASA) physical status I or II
      • Provision of

Exclusion criteria

Exclusion Criteria:

    • Patient refusal to participate

      • to spinal anesthesia or the planned regional block
      • Known allergy or to the medications used in the study
      • Coagulopathy or use of anticoagulant treatment constituting a contraindication to regional anesthesia
      • Infection at the planned needle insertion site
      • Significant neurological or psychiatric disorder affecting pain assessment
      • Inability to understand or use the postoperative pain assessment scale
      • Surgical duration exceeding 120 minutes
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
124 participants (actual)

Study arms

  • No intervention
    Control Group
  • Experimental
    Anterior Quadratus Lumborum Block Group

    Following surgery, an ultrasound-guided unilateral anterior/transmuscular quadratus lumborum block was performed. A total of 20 mL of 0.25% bupivacaine was administered into the fascial plane between the quadratus lumborum and psoas major muscles.

    Procedure: General Aneasthesia

  • Experimental
    Posterior Quadratus Lumborum Block Group

    Following surgery, an ultrasound-guided unilateral posterior quadratus lumborum block was performed. A total of 20 mL of 0.25% bupivacaine was administered at the posterior border of the quadratus lumborum muscle.

    Procedure: General Aneasthesia

  • Experimental
    Paravertebral Block Group

    Following surgery, an ultrasound-guided unilateral thoracic paravertebral block was performed at the T10-T11 level using 20 mL of 0.25% bupivacaine.

    Procedure: General Aneasthesia

Interventions

  • ProcedureGeneral Aneasthesia

    general anesthesia

06

What researchers measure

Primary outcomes

  1. Total Postoperative Analgesic Consumption During the First 24 Hours

    Total rescue analgesic consumption during the first 24 hours after surgery was recorded for each participant.

    Time frame: 0-24 hours after surgery

Secondary outcomes

  1. Requirement for Rescue Analgesia

    The number and proportion of participants requiring rescue analgesic medication during the first 24 postoperative hours were recorded.

    Time frame: 0-24 hours after surgery

  2. Time to First Rescue Analgesic Administration

    The time from completion of surgery/intervention to the first administration of rescue analgesia was recorded.

    Time frame: Up to 24 hours after surgery

07

Study locations

1 site
  • Gaziosmanpaşa Education and Research Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Sep 2023, 6 months.

Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 6 months is below that.

Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 12, 2026
StartActual
Mar 15, 2023
Primary completionActual
Sep 15, 2023
CompletionActual
Sep 15, 2023
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07931846
Responsible party
Döndü Genc Moralar (Doç. Dr, Gaziosmanpasa Research and Education Hospital) — Principal investigator
First posted
Nov 12, 2026
Start date
Mar 15, 2023
Primary completion
Sep 15, 2023
Completion
Sep 15, 2023
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion